Impact in the Reduction of Complications Through a Personalized Follow-Up Strategy to Ensure Adherence to Antihypertensive Therapy
- Autores
- Marín, Gustavo H.; Marín, Lupe; Errecalde, Jorge
- Año de publicación
- 2019
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- The lack in continuity of antihypertensive treatment is one of the major common causes of uncontrolled high blood pressure and increased of adverse effects and medical costs associated to this disease. The current study aimed to investigate the relationship between a personalized strategy that guarantees the adherence to antihypertensive treatment and complications related to hypertension. To do so, 586 patients hypertensive patients attending primary care institutions in La Plata Argentina, were randomly assigned either to an intervention group that had regular and periodically follow up contact to check treatment adherence or to control group. Both groups received free of charge antihypertensive medicines. The adherence was assessed with the adherence evaluation scale of Girerd. The presence of complications of hypertension disease (stroke, angina pectoris, myocardial infarct, transient ischemic attack, heart failure, kidney failure, retinopathy and death associated to this disease) were checked monthly. Among the 293 patients included in the intervention group study 98.63 % (289/293) were adherents while only 49.14% (144/293) of the control group had continuity in the therapy. Comparing complications events developed by patients belonging to Intervention vs Control group after 24 month of follow up were for overall events 19.79% vs 27.98% (p<0.001), for stoke 0.34/1.02%(pNS); angina pectoris 4.09/6.48% (p 0.004), 0.68/1.02 (pNS), TIA 0/0.34% (p NS), heart failure 4.77 /7.16% (p0.003), while hospitalization associate to primary hypertension disease was 16.04/30.3% (p<0.001)respectively. We can conclude that a personalized strategy to guarantee hypertension treatment adherence reduce the hospitalization and several complication associated to this disease.
- Materia
-
Ciencias de la Salud
Adherence
Hypertension
Treatment
Complications - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- http://creativecommons.org/licenses/by/4.0/
- Repositorio
.jpg)
- Institución
- Comisión de Investigaciones Científicas de la Provincia de Buenos Aires
- OAI Identificador
- oai:digital.cic.gba.gob.ar:11746/10486
Ver los metadatos del registro completo
| id |
CICBA_3ce9d7f51139864247556a6637aa0a50 |
|---|---|
| oai_identifier_str |
oai:digital.cic.gba.gob.ar:11746/10486 |
| network_acronym_str |
CICBA |
| repository_id_str |
9441 |
| network_name_str |
CIC Digital (CICBA) |
| spelling |
Impact in the Reduction of Complications Through a Personalized Follow-Up Strategy to Ensure Adherence to Antihypertensive TherapyMarín, Gustavo H.Marín, LupeErrecalde, JorgeCiencias de la SaludAdherenceHypertensionTreatmentComplicationsThe lack in continuity of antihypertensive treatment is one of the major common causes of uncontrolled high blood pressure and increased of adverse effects and medical costs associated to this disease. The current study aimed to investigate the relationship between a personalized strategy that guarantees the adherence to antihypertensive treatment and complications related to hypertension. To do so, 586 patients hypertensive patients attending primary care institutions in La Plata Argentina, were randomly assigned either to an intervention group that had regular and periodically follow up contact to check treatment adherence or to control group. Both groups received free of charge antihypertensive medicines. The adherence was assessed with the adherence evaluation scale of Girerd. The presence of complications of hypertension disease (stroke, angina pectoris, myocardial infarct, transient ischemic attack, heart failure, kidney failure, retinopathy and death associated to this disease) were checked monthly. Among the 293 patients included in the intervention group study 98.63 % (289/293) were adherents while only 49.14% (144/293) of the control group had continuity in the therapy. Comparing complications events developed by patients belonging to Intervention vs Control group after 24 month of follow up were for overall events 19.79% vs 27.98% (p&lt;0.001), for stoke 0.34/1.02%(pNS); angina pectoris 4.09/6.48% (p 0.004), 0.68/1.02 (pNS), TIA 0/0.34% (p NS), heart failure 4.77 /7.16% (p0.003), while hospitalization associate to primary hypertension disease was 16.04/30.3% (p&lt;0.001)respectively. We can conclude that a personalized strategy to guarantee hypertension treatment adherence reduce the hospitalization and several complication associated to this disease.Institute of Research and Journals2019-10info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfhttps://digital.cic.gba.gob.ar/handle/11746/10486enginfo:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by/4.0/reponame:CIC Digital (CICBA)instname:Comisión de Investigaciones Científicas de la Provincia de Buenos Airesinstacron:CICBA2025-10-23T11:14:47Zoai:digital.cic.gba.gob.ar:11746/10486Institucionalhttp://digital.cic.gba.gob.arOrganismo científico-tecnológicoNo correspondehttp://digital.cic.gba.gob.ar/oai/snrdmarisa.degiusti@sedici.unlp.edu.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:94412025-10-23 11:14:47.304CIC Digital (CICBA) - Comisión de Investigaciones Científicas de la Provincia de Buenos Airesfalse |
| dc.title.none.fl_str_mv |
Impact in the Reduction of Complications Through a Personalized Follow-Up Strategy to Ensure Adherence to Antihypertensive Therapy |
| title |
Impact in the Reduction of Complications Through a Personalized Follow-Up Strategy to Ensure Adherence to Antihypertensive Therapy |
| spellingShingle |
Impact in the Reduction of Complications Through a Personalized Follow-Up Strategy to Ensure Adherence to Antihypertensive Therapy Marín, Gustavo H. Ciencias de la Salud Adherence Hypertension Treatment Complications |
| title_short |
Impact in the Reduction of Complications Through a Personalized Follow-Up Strategy to Ensure Adherence to Antihypertensive Therapy |
| title_full |
Impact in the Reduction of Complications Through a Personalized Follow-Up Strategy to Ensure Adherence to Antihypertensive Therapy |
| title_fullStr |
Impact in the Reduction of Complications Through a Personalized Follow-Up Strategy to Ensure Adherence to Antihypertensive Therapy |
| title_full_unstemmed |
Impact in the Reduction of Complications Through a Personalized Follow-Up Strategy to Ensure Adherence to Antihypertensive Therapy |
| title_sort |
Impact in the Reduction of Complications Through a Personalized Follow-Up Strategy to Ensure Adherence to Antihypertensive Therapy |
| dc.creator.none.fl_str_mv |
Marín, Gustavo H. Marín, Lupe Errecalde, Jorge |
| author |
Marín, Gustavo H. |
| author_facet |
Marín, Gustavo H. Marín, Lupe Errecalde, Jorge |
| author_role |
author |
| author2 |
Marín, Lupe Errecalde, Jorge |
| author2_role |
author author |
| dc.subject.none.fl_str_mv |
Ciencias de la Salud Adherence Hypertension Treatment Complications |
| topic |
Ciencias de la Salud Adherence Hypertension Treatment Complications |
| dc.description.none.fl_txt_mv |
The lack in continuity of antihypertensive treatment is one of the major common causes of uncontrolled high blood pressure and increased of adverse effects and medical costs associated to this disease. The current study aimed to investigate the relationship between a personalized strategy that guarantees the adherence to antihypertensive treatment and complications related to hypertension. To do so, 586 patients hypertensive patients attending primary care institutions in La Plata Argentina, were randomly assigned either to an intervention group that had regular and periodically follow up contact to check treatment adherence or to control group. Both groups received free of charge antihypertensive medicines. The adherence was assessed with the adherence evaluation scale of Girerd. The presence of complications of hypertension disease (stroke, angina pectoris, myocardial infarct, transient ischemic attack, heart failure, kidney failure, retinopathy and death associated to this disease) were checked monthly. Among the 293 patients included in the intervention group study 98.63 % (289/293) were adherents while only 49.14% (144/293) of the control group had continuity in the therapy. Comparing complications events developed by patients belonging to Intervention vs Control group after 24 month of follow up were for overall events 19.79% vs 27.98% (p&lt;0.001), for stoke 0.34/1.02%(pNS); angina pectoris 4.09/6.48% (p 0.004), 0.68/1.02 (pNS), TIA 0/0.34% (p NS), heart failure 4.77 /7.16% (p0.003), while hospitalization associate to primary hypertension disease was 16.04/30.3% (p&lt;0.001)respectively. We can conclude that a personalized strategy to guarantee hypertension treatment adherence reduce the hospitalization and several complication associated to this disease. |
| description |
The lack in continuity of antihypertensive treatment is one of the major common causes of uncontrolled high blood pressure and increased of adverse effects and medical costs associated to this disease. The current study aimed to investigate the relationship between a personalized strategy that guarantees the adherence to antihypertensive treatment and complications related to hypertension. To do so, 586 patients hypertensive patients attending primary care institutions in La Plata Argentina, were randomly assigned either to an intervention group that had regular and periodically follow up contact to check treatment adherence or to control group. Both groups received free of charge antihypertensive medicines. The adherence was assessed with the adherence evaluation scale of Girerd. The presence of complications of hypertension disease (stroke, angina pectoris, myocardial infarct, transient ischemic attack, heart failure, kidney failure, retinopathy and death associated to this disease) were checked monthly. Among the 293 patients included in the intervention group study 98.63 % (289/293) were adherents while only 49.14% (144/293) of the control group had continuity in the therapy. Comparing complications events developed by patients belonging to Intervention vs Control group after 24 month of follow up were for overall events 19.79% vs 27.98% (p&lt;0.001), for stoke 0.34/1.02%(pNS); angina pectoris 4.09/6.48% (p 0.004), 0.68/1.02 (pNS), TIA 0/0.34% (p NS), heart failure 4.77 /7.16% (p0.003), while hospitalization associate to primary hypertension disease was 16.04/30.3% (p&lt;0.001)respectively. We can conclude that a personalized strategy to guarantee hypertension treatment adherence reduce the hospitalization and several complication associated to this disease. |
| publishDate |
2019 |
| dc.date.none.fl_str_mv |
2019-10 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://digital.cic.gba.gob.ar/handle/11746/10486 |
| url |
https://digital.cic.gba.gob.ar/handle/11746/10486 |
| dc.language.none.fl_str_mv |
eng |
| language |
eng |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/4.0/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
http://creativecommons.org/licenses/by/4.0/ |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Institute of Research and Journals |
| publisher.none.fl_str_mv |
Institute of Research and Journals |
| dc.source.none.fl_str_mv |
reponame:CIC Digital (CICBA) instname:Comisión de Investigaciones Científicas de la Provincia de Buenos Aires instacron:CICBA |
| reponame_str |
CIC Digital (CICBA) |
| collection |
CIC Digital (CICBA) |
| instname_str |
Comisión de Investigaciones Científicas de la Provincia de Buenos Aires |
| instacron_str |
CICBA |
| institution |
CICBA |
| repository.name.fl_str_mv |
CIC Digital (CICBA) - Comisión de Investigaciones Científicas de la Provincia de Buenos Aires |
| repository.mail.fl_str_mv |
marisa.degiusti@sedici.unlp.edu.ar |
| _version_ |
1846783913318416384 |
| score |
12.982451 |